Cargando…

Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI

BACKGROUND: Myometrial smooth muscle is normally within the field of view for the gynecological imaging. This study aimed to investigate the use of normal myometrium as an internal reference for endometrial and cervical cancer during multiphase contrast-enhanced magnetic resonance imaging (MCE-MRI)...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chia-Ni, Liao, Yu-San, Chen, Wen-Chang, Wang, Yue-Sheng, Lee, Li-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915709/
https://www.ncbi.nlm.nih.gov/pubmed/27326456
http://dx.doi.org/10.1371/journal.pone.0157820
_version_ 1782438727499382784
author Lin, Chia-Ni
Liao, Yu-San
Chen, Wen-Chang
Wang, Yue-Sheng
Lee, Li-Wen
author_facet Lin, Chia-Ni
Liao, Yu-San
Chen, Wen-Chang
Wang, Yue-Sheng
Lee, Li-Wen
author_sort Lin, Chia-Ni
collection PubMed
description BACKGROUND: Myometrial smooth muscle is normally within the field of view for the gynecological imaging. This study aimed to investigate the use of normal myometrium as an internal reference for endometrial and cervical cancer during multiphase contrast-enhanced magnetic resonance imaging (MCE-MRI) and to explore whether this information regarding tumor enhancement relative to the myometrium could be used to discriminate between endometrial and cervical cancer. METHODS: MRI images, before and after contrast enhancement, were analyzed in newly diagnosed cervical (n = 18) and endometrial cancer (n = 19) patients. Signal intensities (SIs) from tumor tissue and non-neoplastic myometrium were measured using imaging software. RESULTS: The relative signal for cervical cancer was approximately 30% higher than that of endometrial cancer after contrast administration. The area under receiver operating characteristic curve for SI, relative signal enhancement, and tumor to myometrium contrast ratio (as used to discriminate between cervical cancer and endometrial cancer) was 0.7807, 0.7456 and 0.7895, respectively. There was no difference in SI of the normal myometrium between endometrial and cervical cancer patients prior to and after contrast administration. Using non-tumorous myometrium as an internal reference, the tumor to myometrium contrast ratio was significantly higher in tumor tissue from cervical cancer compared with that from endometrial cancer at 25 s post contrast enhancement (p = 0.0016), with an optimal sensitivity of 72.22% and specificity of 84.21%. CONCLUSION: With SI normalized to baseline or normal myometrium, tumor tissue from cervical cancer patients showed significant hyperintensity compared with that of tumor tissue from endometrial cancer patients after contrast enhancement, yielding acceptable performance. The use of the myometrium as an internal reference may provide an alternative method to analyze MCE-MRI data.
format Online
Article
Text
id pubmed-4915709
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-49157092016-07-06 Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI Lin, Chia-Ni Liao, Yu-San Chen, Wen-Chang Wang, Yue-Sheng Lee, Li-Wen PLoS One Research Article BACKGROUND: Myometrial smooth muscle is normally within the field of view for the gynecological imaging. This study aimed to investigate the use of normal myometrium as an internal reference for endometrial and cervical cancer during multiphase contrast-enhanced magnetic resonance imaging (MCE-MRI) and to explore whether this information regarding tumor enhancement relative to the myometrium could be used to discriminate between endometrial and cervical cancer. METHODS: MRI images, before and after contrast enhancement, were analyzed in newly diagnosed cervical (n = 18) and endometrial cancer (n = 19) patients. Signal intensities (SIs) from tumor tissue and non-neoplastic myometrium were measured using imaging software. RESULTS: The relative signal for cervical cancer was approximately 30% higher than that of endometrial cancer after contrast administration. The area under receiver operating characteristic curve for SI, relative signal enhancement, and tumor to myometrium contrast ratio (as used to discriminate between cervical cancer and endometrial cancer) was 0.7807, 0.7456 and 0.7895, respectively. There was no difference in SI of the normal myometrium between endometrial and cervical cancer patients prior to and after contrast administration. Using non-tumorous myometrium as an internal reference, the tumor to myometrium contrast ratio was significantly higher in tumor tissue from cervical cancer compared with that from endometrial cancer at 25 s post contrast enhancement (p = 0.0016), with an optimal sensitivity of 72.22% and specificity of 84.21%. CONCLUSION: With SI normalized to baseline or normal myometrium, tumor tissue from cervical cancer patients showed significant hyperintensity compared with that of tumor tissue from endometrial cancer patients after contrast enhancement, yielding acceptable performance. The use of the myometrium as an internal reference may provide an alternative method to analyze MCE-MRI data. Public Library of Science 2016-06-21 /pmc/articles/PMC4915709/ /pubmed/27326456 http://dx.doi.org/10.1371/journal.pone.0157820 Text en © 2016 Lin et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Lin, Chia-Ni
Liao, Yu-San
Chen, Wen-Chang
Wang, Yue-Sheng
Lee, Li-Wen
Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI
title Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI
title_full Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI
title_fullStr Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI
title_full_unstemmed Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI
title_short Use of Myometrium as an Internal Reference for Endometrial and Cervical Cancer on Multiphase Contrast-Enhanced MRI
title_sort use of myometrium as an internal reference for endometrial and cervical cancer on multiphase contrast-enhanced mri
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4915709/
https://www.ncbi.nlm.nih.gov/pubmed/27326456
http://dx.doi.org/10.1371/journal.pone.0157820
work_keys_str_mv AT linchiani useofmyometriumasaninternalreferenceforendometrialandcervicalcanceronmultiphasecontrastenhancedmri
AT liaoyusan useofmyometriumasaninternalreferenceforendometrialandcervicalcanceronmultiphasecontrastenhancedmri
AT chenwenchang useofmyometriumasaninternalreferenceforendometrialandcervicalcanceronmultiphasecontrastenhancedmri
AT wangyuesheng useofmyometriumasaninternalreferenceforendometrialandcervicalcanceronmultiphasecontrastenhancedmri
AT leeliwen useofmyometriumasaninternalreferenceforendometrialandcervicalcanceronmultiphasecontrastenhancedmri